Bio3 Research Srl-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Bio3 Research Srl - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013170
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bio3 Research Srl (Bio3 Research) is a biopharmaceutical company that undertakes the identification and development of therapeutic agents for diseases related to HMGB1 protein over-expression and HMGB1 biological properties. The company develops proprietary compounds with therapeutic potential in cardiovascular, nephrology and tissue regeneration fields. It pipeline product portfolio includes HMGB1 (High Mobility Group Box 1) for cardiovascular disorders; CTR-1 for cartilage repair; CTR-2 for wound healing; CTR-3 for bone matrix regeneration; and BIOCYSAN for renal disorders. The company collaborates with biopharmaceutical companies, academies and individual scientists. Bio3 Research is headquartered in Milan, Italy.

Bio3 Research Srl – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bio3 Research Srl, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bio3 Research Enters Into Distribution Agreement With V.I.Pharma For Biocysan 10
Bio3 Research Enters Into Distribution Agreement With V.I.Pharma For Biocysan 11
Licensing Agreements 12
Bio3 Research Enters into Licensing Agreement with Xediton Pharma for Biocysan 12
Bio3 Research Plans To Enter Into Licensing Agreement For HMGB1 13
Bio3 Research Srl – Key Competitors 14
Bio3 Research Srl – Key Employees 15
Bio3 Research Srl – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Bio3 Research Srl, Pharmaceuticals & Healthcare, Key Facts 2
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bio3 Research Srl, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bio3 Research Srl, Deals By Therapy Area, 2011 to YTD 2017 8
Bio3 Research Srl, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bio3 Research Enters Into Distribution Agreement With V.I.Pharma For Biocysan 10
Bio3 Research Enters Into Distribution Agreement With V.I.Pharma For Biocysan 11
Bio3 Research Enters into Licensing Agreement with Xediton Pharma for Biocysan 12
Bio3 Research Plans To Enter Into Licensing Agreement For HMGB1 13
Bio3 Research Srl, Key Competitors 14
Bio3 Research Srl, Key Employees 15
Bio3 Research Srl, Subsidiaries 16

★海外企業調査レポート[Bio3 Research Srl-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Norsk Hydro ASA:企業のM&A・事業提携・投資動向
    Norsk Hydro ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norsk Hydro ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Nippon Paint Holdings Co Ltd (4612):企業の財務・戦略的SWOT分析
    Nippon Paint Holdings Co Ltd (4612) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PathoQuest SAS:医療機器:M&Aディール及び事業提携情報
    Summary PathoQuest SAS (PathoQuest) is a biotechnology company that provides game changing metagenomics approach to improve the breadth of pathogen detection. The company provides automated bioinformatics software that offers comprehensive pathogens database to produce microbiome reports. Its testin …
  • Graphic Packaging Holding Company:戦略・SWOT・企業財務分析
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Somnomed Ltd (SOM)-医療機器分野:企業M&A・提携分析
    Summary Somnomed Ltd (SomnoMed) is medical device company that develops produces, commercializes and sells device for the oral treatment of sleep related disorders. The company’s products include somnodent, an oral appliance for obstructive sleep apnea; and somnobrux, a mouthguard that protects pati …
  • Xcel Energy Inc:発電所・企業SWOT分析
    Xcel Energy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • TiGenix NV (TIG):企業の財務・戦略的SWOT分析
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …
  • Nabriva Therapeutics plc (NBRV):企業の財務・戦略的SWOT分析
    Summary Nabriva Therapeutics Plc (Nabriva) is a biopharmaceutical company that researches and develops antibiotics for the treatment of infections. The company offers product candidate such as Xenleta (lefamulin), CONTEPO (fosfomycin), being developed in both intravenous and oral formulations for th …
  • Best Western International Inc:企業の戦略・SWOT・財務情報
    Best Western International Inc - Strategy, SWOT and Corporate Finance Report Summary Best Western International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ecobank Transnational Inc:企業の戦略・SWOT・財務情報
    Ecobank Transnational Inc - Strategy, SWOT and Corporate Finance Report Summary Ecobank Transnational Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Curtiss-Wright Corporation (CW)-石油・ガス分野:企業M&A・提携分析
    Summary Curtiss-Wright Corporation (Curtiss-Wright) is a diversified industrial company. It designs, manufactures and overhauls precision components and provides highly engineered and critical-function products, systems and services. Its offerings include sensor handling systems, surface technology …
  • HoMedics USA LLC:企業の戦略的SWOT分析
    HoMedics USA LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Cielo Wind Power, LP-エネルギー分野:企業M&A・提携分析
    Summary Cielo Wind Power, LP (Cielo Wind) is a wind power project development company. It designs, develops, owns and operates utility-grade wind power projects. The company provides a wide range of services including engineering, construction, operations and maintenance, land procurement, meteorolo …
  • JCDecaux SA:企業の戦略・SWOT・財務分析
    JCDecaux SA - Strategy, SWOT and Corporate Finance Report Summary JCDecaux SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Nordson Corporation:企業の戦略・SWOT・財務情報
    Nordson Corporation - Strategy, SWOT and Corporate Finance Report Summary Nordson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Iberia Lineas Aereas de Espana, SA:企業の戦略・SWOT・財務情報
    Iberia Lineas Aereas de Espana, SA - Strategy, SWOT and Corporate Finance Report Summary Iberia Lineas Aereas de Espana, SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Tokyo Electric Power Company Holdings Incorporated (9501):企業の財務・戦略的SWOT分析
    Tokyo Electric Power Company Holdings Incorporated (9501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compan …
  • CenturyLink, Inc.:企業の戦略・SWOT・財務情報
    CenturyLink, Inc. - Strategy, SWOT and Corporate Finance Report Summary CenturyLink, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hansol Logistics Co., Ltd. (009180):企業の財務・戦略的SWOT分析
    Hansol Logistics Co., Ltd. (009180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DTE Energy Co (DTE):企業の財務・戦略的SWOT分析
    DTE Energy Co (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆